OS Therapies Advances OST-HER2 Ahead of ASCO 2026 Presentation
NEW YORK and ROCKVILLE, Md., May 29, 2026 OS Therapies announced the publication of four scientific articles focused on...
Phase 2b trial
Advertisement
Biogen, Denali End BIIB122 Parkinson’s Program
CAMBRIDGE, Massachusetts and SOUTH SAN FRANCISCO, California, May 21, 2026 Biogen Inc. and Denali Therapeutics Inc. announced that the...
TaiMed Advances Long-Acting HIV Therapy Into Late-Stage Development
TAIPEI, Taiwan, 21 May 2026 TaiMed Biologics announced the completion of enrollment in its Phase 2b clinical study evaluating...
Mirum Volixibat Achieves Phase 2b Success in PSC Trial
FOSTER CITY, Calif., May 4, 2026 Mirum Pharmaceuticals, Inc. has announced that its Phase 2b VISTAS clinical study of...
MRM Health Launches Phase 2b UC Trial with MH002
GHENT, Belgium, May 2, 2026 MRM Health announced the initiation of its Phase 2b STARFISH-UC clinical trial (NCT07296315) evaluating...
Advertisements
EnteroBiotix Secures £19M for Phase 2b IBS-C Trial
GLASGOW, Scotland, April 29, 2026 EnteroBiotix Limited has announced the successful completion of a £19 million ($25 million) financing...
Vicore Pharma Completes ASPIRE Trial Enrollment in IPF
Stockholm, Sweden – April 22, 2026 In a significant advancement for respiratory therapeutics, Vicore Pharma has announced the successful...
Nektar Rezpegaldesleukin Shows 52-Week Alopecia Results
SAN FRANCISCO, April 20, 2026 Nektar Therapeutics has reported compelling 52-week topline results from the Phase 2b REZOLVE-AA trial,...
Alpheus Medical Starts Phase 2b Trial in Glioblastoma
CHANHASSEN, Minnesota, April 9, 2026 Alpheus Medical, Inc. has announced the initiation of its Phase 2b randomized clinical trial...
Insmed CEDAR Study Misses Endpoints in HS Trial
BRIDGEWATER, N.J., April 7, 2026 Insmed Incorporated has announced that its Phase 2b CEDAR clinical trial evaluating brensocatib in...
Advertisement
